Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is -4.63.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.63.
EARNINGS PER SHARE (EPS)
-4.63
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eikon Therapeutics, Inc. Common Stock
Market Cap
$415.24M
Earnings Per Share (EPS)
-4.63
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$413.82M
Earnings Per Share (EPS)
-2.08
TTM Avg
-1.97
3Y Avg
-1.74
5Y Avg
-0.94
Market Cap
$419.81M
Earnings Per Share (EPS)
-3.33
TTM Avg
-2.70
3Y Avg
-1.54
5Y Avg
-2.91
Market Cap
$417.83M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.81
3Y Avg
-2.62
5Y Avg
-2.62
Market Cap
$405.64M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$437.37M
Earnings Per Share (EPS)
-0.75
TTM Avg
-2.34
3Y Avg
-2.48
5Y Avg
-2.46
Market Cap
$387.87M
Earnings Per Share (EPS)
-2.94
TTM Avg
-3.49
3Y Avg
-2.70
5Y Avg
-2.28
Market Cap
$444.17M
Earnings Per Share (EPS)
-2.45
TTM Avg
-1.70
3Y Avg
-1.35
5Y Avg
-1.20
Market Cap
$374.16M
Earnings Per Share (EPS)
-0.50
TTM Avg
-5.17
3Y Avg
-17.19
5Y Avg
-12.52
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $415.24M | -4.63 | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $413.82M | -2.08 | -1.97 | -1.74 | -0.94 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $419.81M | -3.33 | -2.70 | -1.54 | -2.91 |
| Carlsmed, Inc. (CARL)vs › | $417.83M | -1.36 | -1.81 | -2.62 | -2.62 |
| Shoulder Innovations, Inc. (SI)vs › | $405.64M | -1.71 | -1.36 | -1.12 | -1.12 |
| Editas Medicine, Inc. (EDIT)vs › | $437.37M | -0.75 | -2.34 | -2.48 | -2.46 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $387.87M | -2.94 | -3.49 | -2.70 | -2.28 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $444.17M | -2.45 | -1.70 | -1.35 | -1.20 |
| Canopy Growth Corporation (CGC)vs › | $374.16M | -0.50 | -5.17 | -17.19 | -12.52 |
| Assembly Biosciences, Inc. (ASMB)vs › | $446.28M | 0.55 | -3.62 | -10.86 | -15.74 |
Trailing EPS (TTM)
$-4.63
Forward EPS (Est.)
$-7.08
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -6.16 |
